Literature DB >> 6337933

Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease.

J E Lennard-Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6337933      PMCID： PMC1419936          DOI： 10.1136/gut.24.3.177

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  25 in total

Review 1.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  M E Pickup
Journal:  Clin Pharmacokinet       Date:  1979 Mar-Apr       Impact factor: 6.447

2.  Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease.

Authors:  J E Lennard-Jones
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

3.  Pharmacokinetics of intravenous and oral prednisolone.

Authors:  S Al-Habet; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

4.  National Cooperative Crohn's Disease Study: results of drug treatment.

Authors:  R W Summers; D M Switz; J T Sessions; J M Becktel; W R Best; F Kern; J W Singleton
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

5.  Serum prednisolone levels in Crohn's disease and coeliac disease following oral prednisolone administration.

Authors:  A R Tanner; J W Halliday; L W Powell
Journal:  Digestion       Date:  1981       Impact factor: 3.216

6.  A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis.

Authors:  J Powell-Tuck; R L Bown; J E Lennard-Jones
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

7.  Prednisolone absorption in acute colitis.

Authors:  P R Elliott; J Powell-Tuck; P E Gillespie; J M Laidlow; J E Lennard-Jones; J English; J Chakraborty; V Marks
Journal:  Gut       Date:  1980-01       Impact factor: 23.059

8.  Rectally administered prednisolone--evidence for a predominantly local action.

Authors:  D A Lee; M Taylor; V H James; G Walker
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

9.  A controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission.

Authors:  J Powell-Tuck; R L Bown; T J Chambers; J E Lennard-Jones
Journal:  Digestion       Date:  1981       Impact factor: 3.216

10.  Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay.

Authors:  C J Hawkey; S C Truelove
Journal:  Gut       Date:  1981-03       Impact factor: 23.059
View more
  8 in total

Review 1.  Steroids: a surgeon's view.

Authors:  J A Smith
Journal:  Arch Emerg Med       Date:  1985-09

Review 2.  Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors:  S B Hanauer; G Stathopoulos
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

3.  Frequency of glucocorticoid resistance and dependency in Crohn's disease.

Authors:  P Munkholm; E Langholz; M Davidsen; V Binder
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

4.  The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation.

Authors:  A Shaked; J O Colonna; L Goldstein; R W Busuttil
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

Review 5.  Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy.

Authors:  Julián Panés; Jordi Rimola
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-09       Impact factor: 46.802

6.  Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis.

Authors:  Yasushi Umehara; Masatoshi Kudo; Masanori Kawasaki
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

Review 7.  Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.

Authors:  F Scaldaferri; V Petito; L Lopetuso; G Bruno; V Gerardi; G Ianiro; A Sgambato; A Gasbarrini; G Cammarota
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

8.  Inhibition of the production of mediators of inflammation by corticosteroids is a glucocorticoid receptor-mediated process.

Authors:  G S Madretsma; A P Dijk; C J Tak; J H Wilson; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.